SDH mutations, as potential predictor of chemotherapy prognosis in small cell lung cancer patients

SDH mutations, as potential predictor of chemotherapy prognosis in small cell lung cancer patients

Abstract Purpose Small cell lung cancer (SCLC) is an aggressive and rapidly progressive malignant tumor characterized by a poor prognosis. Chemotherapy remains the primary treatment in clinical practice; however, reliable biomarkers for predicting chemotherapy outcomes are scarce. Methods In this st...

Full description

Bibliographic Details
Main Authors: Ran Zeng, Xiaoyun Fan, Jin Yang, Chen Fang, Jieyi Li, Wei Wen, Jing Liu, Mengchen Lv, Xiangran Feng, XiaoKai Zhao, Hongjie Yu, Yuhuan Zhang, Xianwen Sun, Zhiyao Bao, Jun Zhou, Lei Ni, Xiaofei Wang, Qijian Cheng, Beili Gao, Ziying Gong, Daoyun Zhang, Yuchao Dong, Yi Xiang
Format: Article
Language:English
Published: Springer 2023-06-01
Series:Discover Oncology
Subjects:
SCLC
SDH mutations
Chemotherapy prognostic
Random forest
Next generation sequencing
Online Access:https://doi.org/10.1007/s12672-023-00685-4

Internet

https://doi.org/10.1007/s12672-023-00685-4

Similar Items